|
Form 4 Filings | Insider Buys | Significant Buys |
Penny Stocks Insider Buying |
Insider Sales |
| Insider Buy Sell Ratios | Stock Options |
Insider Trading Stock Screener |
Insider Trading Graph View |
Insider Watch |
Insider Trading - Zynerba Pharmaceuticals Inc. (ZYNE)
|
|
"Insiders might sell their shares for any number of reasons, but they buy them for only one:
they think the price will rise"
- Peter Lynch What is insider trading>> |
Historical filings delayed by 6 months. New user? Sign Up for real time data. Existing user? Sign In
Common stock purchase or sale:
| Transaction Date |
Reported DateTime |
Company | Symbol | Insider Relationship |
Shares Traded |
Average Price |
Total Amount |
Shares Owned |
Filing |
| 2018-08-22 Purchase |
2018-08-22 4:39 pm |
Zynerba Pharmaceuticals Inc. | ZYNE | Butler John P. Director |
5,000 | $6.431 | $32,153 | 5,000 (Direct) |
View |
| 2018-08-06 Purchase |
2018-08-07 4:32 pm |
Zynerba Pharmaceuticals Inc. | ZYNE | ANIDO ARMANDO CEO, Chairman |
15,000 | $5.962 | $89,423 | 352,512 (Indirect Direct) |
View |
| 2018-08-06 Purchase |
2018-08-07 4:30 pm |
Zynerba Pharmaceuticals Inc. | ZYNE | Hanlon Suzanne M. VP |
3,800 | $5.802 | $22,048 | 43,693 (Direct) |
View |
| 2018-08-06 Purchase |
2018-08-07 4:29 pm |
Zynerba Pharmaceuticals Inc. | ZYNE | Sebree Terri B President |
3,800 | $5.793 | $22,013 | 182,546 (Direct) |
View |
| 2018-08-06 Purchase |
2018-08-07 4:28 pm |
Zynerba Pharmaceuticals Inc. | ZYNE | Fickenscher James E CFO |
8,518 | $5.969 | $50,842 | 20,718 (Direct) |
View |
| 2018-05-30 Purchase |
2018-05-31 09:26 am |
Zynerba Pharmaceuticals Inc. | ZYNE | RAPP MICHAEL 10% Owner |
5,885 | $10.45 | $61,498 | 1,500,000 (Direct) |
View |
| 2018-03-22 Purchase |
2018-05-02 5:38 pm |
Zynerba Pharmaceuticals Inc. | ZYNE | RAPP MICHAEL 10% Owner |
15,000 | $10.46 | $156,945 | 1,494,115 (Direct) |
View |
| 2018-03-22 Purchase |
2018-03-23 09:30 am |
Zynerba Pharmaceuticals Inc. | ZYNE | RAPP MICHAEL 10% Owner |
10,000 | $9.279 | $92,790 | 1,479,115 (Direct) |
View |
| 2018-01-02 Purchase |
2018-01-03 06:05 am |
Zynerba Pharmaceuticals Inc. | ZYNE | RAPP MICHAEL 10% Owner |
15,000 | $12.99 | $194,847 | 1,469,115 (Direct) |
View |
| 2017-10-19 Purchase |
2017-10-23 7:25 pm |
Zynerba Pharmaceuticals Inc. | ZYNE | RAPP MICHAEL 10% Owner |
100,000 | $9.737 | $973,738 | 1,454,115 (Direct) |
View |
Stock options: Exercise, Award, Grant, Conversion
| Transaction Date |
Reported DateTime |
Exercisable Expiration |
Company | Symnbol | Insider Relationship |
Shares Traded |
Conversion Price |
Shares Owned |
Filing |
| 2019-01-24 Option Award |
2019-01-30 4:12 pm |
N/A 2029-01-24 |
Zynerba Pharmaceuticals Inc. | ZYNE | ANIDO ARMANDO CEO, Chairman |
160,000 | $3.65 | 160,000 (Direct) |
View |
| 2019-01-24 Option Award |
2019-01-28 4:20 pm |
N/A 2029-01-24 |
Zynerba Pharmaceuticals Inc. | ZYNE | Hanlon Suzanne M. VP |
52,859 | $3.65 | 52,859 (Direct) |
View |
| 2019-01-24 Option Award |
2019-01-28 4:20 pm |
N/A N/A |
Zynerba Pharmaceuticals Inc. | ZYNE | Sebree Terri B President |
3,600 | $0 | 186,146 (Direct) |
View |
| 2019-01-24 Option Award |
2019-01-28 4:20 pm |
N/A 2029-01-24 |
Zynerba Pharmaceuticals Inc. | ZYNE | Sebree Terri B President |
120,000 | $3.65 | 186,146 (Direct) |
View |
| 2019-01-24 Option Award |
2019-01-28 4:15 pm |
N/A 2019-01-24 |
Zynerba Pharmaceuticals Inc. | ZYNE | ANIDO ARMANDO CEO, Chairman |
160,000 | $3.65 | 160,000 (Direct) |
View |
| 2019-01-24 Option Award |
2019-01-28 4:14 pm |
N/A 2029-01-24 |
Zynerba Pharmaceuticals Inc. | ZYNE | Fickenscher James E CFO |
88,099 | $3.65 | 88,099 (Direct) |
View |
| 2019-01-24 Option Award |
2019-01-28 4:14 pm |
N/A 2029-01-24 |
Zynerba Pharmaceuticals Inc. | ZYNE | Rosenberger Brian VP |
42,287 | $3.65 | 42,287 (Direct) |
View |
| 2019-01-02 Option Award |
2019-01-04 10:10 am |
2019-01-02 2029-01-02 |
Zynerba Pharmaceuticals Inc. | ZYNE | MOCH KENNETH I Director |
2,450 | $2.424 | 2,450 (Direct) |
View |
| 2018-10-01 Option Award |
2018-10-02 4:24 pm |
2018-10-01 2028-10-01 |
Zynerba Pharmaceuticals Inc. | ZYNE | FEDERICI WILLIAM J Director |
1,334 | $5.156 | 1,334 (Direct) |
View |
| 2018-10-01 Option Award |
2018-10-02 4:22 pm |
2018-10-01 2028-10-01 |
Zynerba Pharmaceuticals Inc. | ZYNE | MOCH KENNETH I Director |
1,152 | $5.156 | 1,152 (Direct) |
View |
| 2018-07-02 Option Award |
2018-07-03 3:15 pm |
2018-07-02 2028-07-02 |
Zynerba Pharmaceuticals Inc. | ZYNE | MOCH KENNETH I Director |
952 | $6.235 | 952 (Direct) |
View |
| 2018-07-02 Option Award |
2018-07-03 3:13 pm |
2018-07-02 2028-07-02 |
Zynerba Pharmaceuticals Inc. | ZYNE | FEDERICI WILLIAM J Director |
1,103 | $6.235 | 1,103 (Direct) |
View |
| 2018-06-06 Option Award |
2018-06-07 4:32 pm |
N/A 2028-06-06 |
Zynerba Pharmaceuticals Inc. | ZYNE | FEDERICI WILLIAM J Director |
15,000 | $11.3 | 15,000 (Direct) |
View |
| 2018-06-06 Option Award |
2018-06-07 4:31 pm |
N/A 2028-06-06 |
Zynerba Pharmaceuticals Inc. | ZYNE | HARRISON THOMAS L Director |
15,000 | $11.3 | 15,000 (Direct) |
View |
| 2018-06-06 Option Award |
2018-06-07 4:30 pm |
N/A 2028-06-06 |
Zynerba Pharmaceuticals Inc. | ZYNE | KISNER DANIEL L Director |
15,000 | $11.3 | 15,000 (Direct) |
View |
| 2018-06-06 Option Award |
2018-06-07 4:30 pm |
N/A 2028-06-06 |
Zynerba Pharmaceuticals Inc. | ZYNE | Butler John P. Director |
15,000 | $11.3 | 15,000 (Direct) |
View |
| 2018-06-06 Option Award |
2018-06-07 4:29 pm |
N/A 2028-06-06 |
Zynerba Pharmaceuticals Inc. | ZYNE | COOPER WARREN D Director |
15,000 | $11.3 | 15,000 (Direct) |
View |
| 2018-06-06 Option Award |
2018-06-07 4:23 pm |
N/A 2028-06-06 |
Zynerba Pharmaceuticals Inc. | ZYNE | MOCH KENNETH I Director |
15,000 | $11.3 | 15,000 (Direct) |
View |
| 2018-04-12 Option Award |
2018-04-16 4:15 pm |
2018-04-12 2028-04-12 |
Zynerba Pharmaceuticals Inc. | ZYNE | Butler John P. Director |
35,000 | $9.9 | 35,000 (Direct) |
View |
| 2018-04-02 Option Award |
2018-04-03 4:15 pm |
2018-04-02 2028-04-02 |
Zynerba Pharmaceuticals Inc. | ZYNE | MOCH KENNETH I Director |
1,161 | $5.115 | 1,161 (Direct) |
View |
| 2018-04-02 Option Award |
2018-04-03 4:15 pm |
2018-04-02 2028-04-02 |
Zynerba Pharmaceuticals Inc. | ZYNE | FEDERICI WILLIAM J Director |
1,344 | $5.115 | 1,344 (Direct) |
View |
| 2018-01-11 Option Award |
2018-01-16 4:11 pm |
N/A 2028-01-11 |
Zynerba Pharmaceuticals Inc. | ZYNE | Fickenscher James E CFO |
67,500 | $11.71 | 67,500 (Direct) |
View |
| 2018-01-11 Option Award |
2018-01-16 4:11 pm |
N/A 2028-01-11 |
Zynerba Pharmaceuticals Inc. | ZYNE | Hanlon Suzanne M. VP |
42,700 | $11.71 | 42,700 (Direct) |
View |
| 2018-01-11 Option Award |
2018-01-16 4:11 pm |
N/A 2028-01-11 |
Zynerba Pharmaceuticals Inc. | ZYNE | Rosenberger Brian VP |
42,000 | $11.71 | 42,000 (Direct) |
View |
| 2018-01-11 Option Award |
2018-01-16 4:10 pm |
N/A 2028-01-11 |
Zynerba Pharmaceuticals Inc. | ZYNE | Sebree Terri B President |
43,920 | $11.71 | 43,920 (Direct) |
View |
| 2018-01-11 Option Award |
2018-01-16 4:10 pm |
N/A 2028-01-11 |
Zynerba Pharmaceuticals Inc. | ZYNE | ANIDO ARMANDO CEO, Chairman |
81,000 | $11.71 | 81,000 (Direct) |
View |
| 2018-01-02 Option Award |
2018-01-04 4:07 pm |
2018-01-02 2028-01-02 |
Zynerba Pharmaceuticals Inc. | ZYNE | MOCH KENNETH I Director |
716 | $8.289 | 716 (Direct) |
View |
| 2018-01-02 Option Award |
2018-01-04 4:06 pm |
2018-01-02 2028-01-02 |
Zynerba Pharmaceuticals Inc. | ZYNE | FEDERICI WILLIAM J Director |
754 | $8.289 | 754 (Direct) |
View |
| 2017-10-02 Option Award |
2017-10-03 4:06 pm |
2017-10-02 2027-10-02 |
Zynerba Pharmaceuticals Inc. | ZYNE | HARRISON THOMAS L Director |
2,057 | $5.47 | 2,057 (Direct) |
View |
| 2017-10-02 Option Award |
2017-10-03 4:06 pm |
2017-10-02 2027-10-02 |
Zynerba Pharmaceuticals Inc. | ZYNE | MOCH KENNETH I Director |
971 | $5.47 | 971 (Direct) |
View |
| 2017-10-02 Option Award |
2017-10-03 4:05 pm |
2017-10-02 2027-10-02 |
Zynerba Pharmaceuticals Inc. | ZYNE | FEDERICI WILLIAM J Director |
1,714 | $5.47 | 1,714 (Direct) |
View |
|
© 2005-2019 SecForm4.Com All rights reserved. Archives: 2019 2018 2017 2016 2015 2014 ... Sat, 17 Aug 2019 05:51:13 -0500 |
SEC is the U.S. Securities and Exchange Commission. EDGAR is a trademark of the SEC.
SecForm4.Com is not affiliated with or approved by the U.S. Securities and Exchange Commission (SEC). Terms of Use | Privacy Statement | |